Mr. Quang Pham

Chairman and CEO


Quang Pham is a biopharmaceutical entrepreneur with over 20 years of experience in founding, financing, and growing companies. He has served as our Chief Executive Officer and Chairman since he founded Espero in 2014.

Mr. Lee Golden, M.D.

Chief Medical Officer


Lee Golden, M.D., has served as Chief Medical Officer since October 2018.  Prior to joining the company, Dr. Golden served as the Chief Medical Officer at Gemphire (NASDAQ: GEMP), a clinical stage biopharmaceutical company that is developing and commercializing therapies for cardiometabolic disorders, where he oversaw clinical development and regulatory activities.

Mr. Jeff Cole

President and CFO


Mr. Cole has over 23 years of experience in finance, business development and commercial operations at public and privately held companies. This includes more than 15 years in the pharmaceutical industry holding various senior executive roles at companies such as Valeant Pharmaceuticals (NYSE: VRX), Solco Healthcare US, MarcasUSA, and Legacy Pharmaceuticals. His positions at Valeant included CFO North America, VP of Corporate Development, and General Manager of the US Specialty Division.

Mr. Pascal Druzgala
Pharm.D., Ph.D.

Senior Vice President,
Research & Development


Dr. Druzgala was a co-founder of Armetheon, where he served as Senior Vice President, Research & Development. He was in charge of all discovery programs. Dr. Druzgala was also a co-founder and board member of Optivia Biotechnology, and a co-founder of ARYx Therapeutics (NASDAQ:ARYX), where he served as senior VP and CSO from 1997 to 2011 as well as chairman of the scientific advisory board.

Mr. Andrew Lam

Vice President, Product Development


Mr. Lam is currently Vice President of Product Development at Espero BioPharma, where he leads the CMC development and pharmaceutical operations.  Prior to joining Espero, Mr. Lam has more than 24 years of experience in pharmaceutical product development, with a primary focus in the development of controlled release products.